13F HOLDINGS REPORT
Patient Square Capital LP
Quarter ended Q2 2025 · Filed August 11, 2025 · Accession 0000950123-25-007478
Total Value
$277.4M
Positions
19
Other Managers
0
Confidential Omitted
No
Holdings (19)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ROIVANT SCIENCES LTD. | ROIV | 12,480,000 | $140.6M | 50.71% |
| 2 | INSMED INC | INSM | 358,800 | $36.1M | 13.02% |
| 3 | ARGENX SE - ADR | ARGX | 29,000 | $16.0M | 5.76% |
| 4 | EYEPOINT PHARMACEUTICALS, INC. | EYPT | 1,352,837 | $12.7M | 4.59% |
| 5 | LIQUIDIA CORPORATION | LQDA | 1,020,000 | $12.7M | 4.58% |
| 6 | OCULAR THERAPEUTIX, INC. | OCUL | 817,699 | $7.6M | 2.74% |
| 7 | CULLINAN THERAPEUTICS, INC. | CGEM | 868,897 | $6.5M | 2.36% |
| 8 | KYMERA THERAPEUTICS, INC. | KYMR | 140,000 | $6.1M | 2.20% |
| 9 | MIRUM PHARMACEUTICALS, INC. | MIRM | 113,462 | $5.8M | 2.08% |
| 10 | SCHOLAR ROCK HOLDING CORPORATION | SRRK | 154,000 | $5.5M | 1.97% |
| 11 | ENLIVEN THERAPEUTICS, INC. | ELVN | 245,838 | $4.9M | 1.78% |
| 12 | NURIX THERAPEUTICS, INC. | NRIX | 412,296 | $4.7M | 1.69% |
| 13 | AGIOS PHARMACEUTICALS, INC. | AGIO | 139,732 | $4.6M | 1.68% |
| 14 | PHARVARIS N. V. | PHVS | 244,283 | $4.3M | 1.55% |
| 15 | DISC MEDICINE, INC. | IRON | 74,000 | $3.9M | 1.41% |
| 16 | ALLOGENE THERAPEUTICS, INC. | ALLO | 2,635,000 | $3.0M | 1.07% |
| 17 | GERON CORP | GERN | 716,000 | $1.0M | 0.36% |
| 18 | CIDARA THERAPEUTICS INC | 171757206 | 15,000 | $730,650 | 0.26% |
| 19 | VYNE THERAPEUTICS INC. | VYNE | 317,033 | $523,104 | 0.19% |